A Phase I/II Open-label Multicenter Trial to Evaluate Safety and Preliminary Efficacy of Unilateral Deep Brain Stimulation of the Mesencephalic Locomotor Region in Patients With Incomplete Spinal Cord Injury

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Spinal cord injuries are anatomically mostly incomplete, showing tissue bridges of the spinal cord at the injury site. Of the 60% functionally incomplete patients, about half face a life in the wheelchair. Besides conventional rehabilitation, no prominsing further treatment options exist. One of the most plastic systems involved in locomotion is the pontomedullary reticulospinal tract, which is the oldest locomotor command system existing in most vertebrates, including primates. Muscle activation patterns for limb movements are programmed in the spinal cord and have to be activated and coordinated through commands from the so called mesencephalic locomotor region (MLR). The MLR consists of nerve cells in the lower mesencephalic tegmentum sending uni- and bilateral signals through the medullary reticulospinal tracts. Classical physiological studies showed that electrical stimulation of the MLR induce locomotion. For the first time this approach was transferred and recently published in a model of induced incomplete spinal cord injury by the Schwab group. Rats severly impaired in motor hindlimb control with only 10-20% spared white matter, recovered with fully functional weight bearing locomotion under MLR deep brain stimulation (DBS). Even rats with only 2-10% spared white matter regained weight supporting stepping. DBS is a clinical standard treatment option in patients with movement disorders but does not relieve all symptoms. Therefore, small studies of MLR stimulations have been safely used in Parkinsonian patients showing freezing of gait and frequent falls with variable results. In a translational approach, we aim at performing a multidisciplinary phase one clinical trial with 5 patients and incomplete spinal cord injury. With the means of our established universitary setup for DBS treatments the operations will be performed unilaterally under local anaesthesia in the Division of Neurosurgery, USZ, with perioperative electrophysiological recordings, clinical assessments and gait analysis under test stimulation in the Spinal Cord Injury Center Balgrist.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Informed Consent

• Participation in two assessment sessions before enrollment (Screening and baseline)

• Willingness and ability to comply with the protocol and to attend required study training and visits

• Male or female subjects

• Age 18-75

• Motor incomplete SCI

• Level of lesion: T10 and above, based on AIS level, preservation of sacral function

• Focal spinal cord disorder caused by either trauma or non-traumatic and non-progressive condition (like hemorrhage, benign tumor)

• Minimum 3 months of recovery after SCI, maximum 2 years after trauma

⁃ Completed in-patient rehabilitation program

⁃ WISCI II, level \>2 (0-20 items): assistance of one or more persons. Ability to walk at least 10 meters

⁃ Stable medical and physical condition.

⁃ Adequate care-giver support and access to appropriate medical care in patient's home community

Locations
Other Locations
Switzerland
Balgrist University Hospital
RECRUITING
Zurich
Contact Information
Primary
Lennart H Stieglitz, MD
Lennart.Stieglitz@usz.ch
+4144255
Backup
Iris Krüsi
DBS-SCI@balgrist.ch
+4144386
Time Frame
Start Date: 2018-03-15
Estimated Completion Date: 2027-12
Participants
Target number of participants: 5
Treatments
Experimental: Intervention group
Single-armed study. All patients will receive treatment.
Sponsors
Collaborators: Balgrist University Hospital, Wings for Life, ETH Zurich
Leads: University of Zurich

This content was sourced from clinicaltrials.gov